After a slow start that saw the first four horses and five of the first seven fail to meet their reserve prices, the second session of the Fasig-Tipton Saratoga select yearling sale Aug. 5 saw steady momentum gains that led to the third million-dollar horse of the sale.
While the number horses failing to meet their reserves (RNAs)–20–was nearly three times the seven that did not meet reserves on the sale’s first night Aug. 4, the average price of the second session was up 7.5% over last year’s corresponding session to $300,340, with the median decreasing slightly, down 5% to $237,500.
“The RNAs crept up, and that had to be expected,” said Fasig-Tipton’s president and CEO Boyd Browning. “For the combined sale, it was under 20%, and we had a very successful two-night sale. Overall, it’s a very healthy market.”
Read more on BloodHorse.com…
Featured image: sale-topping hip 150, purchased for $1.25 million by Willis Horton. Photo courtesy of Fasig-Tipton.